RE:RE:RE:RE:RE:For those that Sold at 0.26 CAD TodayWe are due for some PR since sometime. Last one was for the appointment for commercialization of serology test. All pp are not nessecary bad, how else are we gonna keep finding cash to fund these research unless we have revenue from serology. Last one was pp for convertible debentures, which gave us new life. They filed short term prospectus on March 5th and funding announcement by end of march. Not sure how it will play out this time . Also I guess it is safe to assume that , any further funding will be from Boston group as they risked lending us before biogen . Also There was a previous ppt they specifically talked about funding assurance from bankers after biogen approval. But now I can't find it ..